C

Crossject
ALCJ

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€127.63M
EV
€141.57M
Shares Outstanding
53.74M
Beta
0.57
Industry
Medical - Instruments & Supplies

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
1
P/E 2025E
4.57x
P/Revenue 2025E
2.34x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Crossject Société Anonyme

gainify

C

Crossject Société Anonyme

ALCJ

Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, a needle-free device for patient-side management disorders self-injectables. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid over...

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Alexandre, Patrick

Employees

102

IPO Date

2014-02-20

Headquarters

6 Rue Pauline Kergomard, Dijon, Burgundy, 21000, France

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.